MetLife stock snapshot and recent performance
MetLife (MET) sits in focus today as investors weigh its recent share performance against the scale of its global insurance and benefits franchise, including US$77,079m in revenue and US$3,173m in net income.
The stock has delivered a 38.36% total return over the past 3 years and 32.4% over the past 5 years, even as it shows negative returns over the past year and month.
See our latest analysis for MetLife.
At a share price of US$69.89, MetLife has seen a 30 day share price return of 11.64% and a year to date share price return of 12.99%, while the 3 year total shareholder return of 38.36% contrasts with a 1 year total shareholder return of 14.06%. This suggests that longer term momentum has cooled recently.
If MetLife's recent pullback has you reconsidering where growth or income could come from next, it can help to broaden your search with 20 top founder-led companies
With MetLife trading at US$69.89, and showing recent share price declines and a value score of 4, the key question is whether the current valuation reflects a margin of safety or if markets are already pricing in future growth.
Most Popular Narrative: 23% Undervalued
MetLife's most followed narrative points to a fair value of $90.73 per share, compared with the last close at $69.89, which is a material gap that centers attention on what is driving that estimate.
Strategic expansion of asset-light, fee-generating businesses (like employee benefits, asset management, and longevity reinsurance), combined with disciplined capital management, supports higher return on equity and more consistent, less capital-intensive earnings growth.
Curious what sits underneath that fair value? The narrative focuses on revenue trends, margins, and an earnings multiple that reflects those factors.
Result: Fair Value of $90.73 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, investors still need to watch interest rate pressure on investment yields and the risk that slower digital adoption leaves MetLife exposed to more agile competitors.
Find out about the key risks to this MetLife narrative.
Next Steps
Given the mix of concerns and optimism in this story, now is a good moment to review the numbers yourself, weigh both sides, and see the 4 key rewards and 2 important warning signs.
Looking for more investment ideas?
If MetLife has sharpened your thinking, do not stop here. Broaden your watchlist now or you risk missing opportunities sitting in plain sight.
- Spot potential bargains faster by scanning 58 high quality undervalued stocks that combine quality fundamentals with pricing that may appeal to value focused investors.
- Strengthen your income stream by reviewing 13 dividend fortresses that prioritise higher yields alongside company resilience.
- Sleep easier at night by focusing on 73 resilient stocks with low risk scores that score well on financial health and stability.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com